The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study

AimsNon-alcoholic fatty liver disease (NAFLD) has a dynamic disease course, therefore repeated measurements of NAFLD status could have benefits rather than single one. The aim of this study was to investigate the effects of persistent NAFLD on the incidence of myocardial infarction (MI) and stroke a...

Full description

Bibliographic Details
Main Authors: Chang-Hoon Lee, Kyung-Do Han, Da Hye Kim, Min-Sun Kwak
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.638615/full
_version_ 1818959129989873664
author Chang-Hoon Lee
Kyung-Do Han
Da Hye Kim
Min-Sun Kwak
author_facet Chang-Hoon Lee
Kyung-Do Han
Da Hye Kim
Min-Sun Kwak
author_sort Chang-Hoon Lee
collection DOAJ
description AimsNon-alcoholic fatty liver disease (NAFLD) has a dynamic disease course, therefore repeated measurements of NAFLD status could have benefits rather than single one. The aim of this study was to investigate the effects of persistent NAFLD on the incidence of myocardial infarction (MI) and stroke and all-cause mortality by using repeated measurement of fatty liver index (FLI).MethodsAbout 3 million subjects who had undergone the health screening four times from 2009 until 2013 were included. NAFLD was defined as an FLI ≥60. FLI points were defined as the number of times participants meeting the criteria of NAFLD (0–4). Outcomes included all-cause mortality, MI, and stroke.ResultsThe higher the FLI points, the higher the risk of all-cause mortality, MI, and stroke (P for trend <0.001, all). Subjects with four FLI points had a higher risk of all-cause mortality (aHR, 1.86; 95% CI, 1.75–1.98; P < 0.001), incidence of MI (aHR, 1.3; 95% CI, 1.21–1.40; P < 0.001), and stroke (aHR, 1.27; 95% CI, 1.19–1.37; P < 0.001) after adjustment for age, sex, smoking, alcohol consumption, income, hypertension, dyslipidemia, diabetes, body mass index, and physical activity. When the 1st and the last FLI were compared, the “incident NAFLD” group had a higher risk for death compared to the “no NAFLD” group (aHR, 1.46; 95% CI, 1.37–1.55), and the “regression of NAFLD” group had a decreased risk for death compared to the “persistent NAFLD” group (aHR, 0.83; 95% CI, 0.77–0.89).ConclusionRepeated evaluations of NAFLD status based on FLI measurements could help physicians identify higher-risk groups in terms of mortality, MI, and stroke. The association between FLI worsening or improvement and outcomes also suggests clinical benefits of the prevention and treatment of NAFLD.
first_indexed 2024-12-20T11:36:44Z
format Article
id doaj.art-5196b3d2ce59493a99fc1d0092788b6a
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-20T11:36:44Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-5196b3d2ce59493a99fc1d0092788b6a2022-12-21T19:42:05ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-03-011210.3389/fendo.2021.638615638615The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort StudyChang-Hoon Lee0Kyung-Do Han1Da Hye Kim2Min-Sun Kwak3Department of Internal Medicine, Seoul National University Hospital, Seoul, South KoreaDepartment of Statistics and Actuarial Science, Soongsil University, Seoul, South KoreaDepartment of Biostatistics, Catholic University of Korea, Seoul, South KoreaDepartment of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, South KoreaAimsNon-alcoholic fatty liver disease (NAFLD) has a dynamic disease course, therefore repeated measurements of NAFLD status could have benefits rather than single one. The aim of this study was to investigate the effects of persistent NAFLD on the incidence of myocardial infarction (MI) and stroke and all-cause mortality by using repeated measurement of fatty liver index (FLI).MethodsAbout 3 million subjects who had undergone the health screening four times from 2009 until 2013 were included. NAFLD was defined as an FLI ≥60. FLI points were defined as the number of times participants meeting the criteria of NAFLD (0–4). Outcomes included all-cause mortality, MI, and stroke.ResultsThe higher the FLI points, the higher the risk of all-cause mortality, MI, and stroke (P for trend <0.001, all). Subjects with four FLI points had a higher risk of all-cause mortality (aHR, 1.86; 95% CI, 1.75–1.98; P < 0.001), incidence of MI (aHR, 1.3; 95% CI, 1.21–1.40; P < 0.001), and stroke (aHR, 1.27; 95% CI, 1.19–1.37; P < 0.001) after adjustment for age, sex, smoking, alcohol consumption, income, hypertension, dyslipidemia, diabetes, body mass index, and physical activity. When the 1st and the last FLI were compared, the “incident NAFLD” group had a higher risk for death compared to the “no NAFLD” group (aHR, 1.46; 95% CI, 1.37–1.55), and the “regression of NAFLD” group had a decreased risk for death compared to the “persistent NAFLD” group (aHR, 0.83; 95% CI, 0.77–0.89).ConclusionRepeated evaluations of NAFLD status based on FLI measurements could help physicians identify higher-risk groups in terms of mortality, MI, and stroke. The association between FLI worsening or improvement and outcomes also suggests clinical benefits of the prevention and treatment of NAFLD.https://www.frontiersin.org/articles/10.3389/fendo.2021.638615/fullhepatic steatosisnon-invasive testmortalitycardiovascular diseasefatty liver
spellingShingle Chang-Hoon Lee
Kyung-Do Han
Da Hye Kim
Min-Sun Kwak
The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
Frontiers in Endocrinology
hepatic steatosis
non-invasive test
mortality
cardiovascular disease
fatty liver
title The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
title_full The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
title_fullStr The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
title_full_unstemmed The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
title_short The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
title_sort repeatedly elevated fatty liver index is associated with increased mortality a population based cohort study
topic hepatic steatosis
non-invasive test
mortality
cardiovascular disease
fatty liver
url https://www.frontiersin.org/articles/10.3389/fendo.2021.638615/full
work_keys_str_mv AT changhoonlee therepeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT kyungdohan therepeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT dahyekim therepeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT minsunkwak therepeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT changhoonlee repeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT kyungdohan repeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT dahyekim repeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy
AT minsunkwak repeatedlyelevatedfattyliverindexisassociatedwithincreasedmortalityapopulationbasedcohortstudy